Milacemide, a glycine pro-drug, inhibits strychnine-allodynia without affecting normal nociception in the rat

Pain

Volumn 77, Issue 1, 1998, Pages 87-95

  Khandwala, Hemal ^a   Loomis, Christopher W ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Allodynia; Milacemide; Monoamine oxidase; Nociception; Rat; Spinal; Strychnine

Indexed keywords

ANTICONVULSIVE AGENT; CLORGYLINE; GLYCINE RECEPTOR; MILACEMIDE; MONOAMINE OXIDASE INHIBITOR; SELEGILINE; STRYCHNINE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTROENCEPHALOGRAM; HEART RATE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETAMIDES; ANIMALS; ANTICONVULSANTS; CLORGYLINE; GLYCINE; HYPERALGESIA; INJECTIONS, INTRAVENOUS; INJECTIONS, SPINAL; MALE; MONOAMINE OXIDASE INHIBITORS; NOCICEPTORS; PRODRUGS; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; SELEGILINE; STRYCHNINE;

EID: 0031656553     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00086-4     Document Type: Article

References (29)

1. Beyer C., Roberts L.A., Komisruk B.R. Hyperalgesia induced by altered glycinergic activity at the spinal cord. Life Sci. 37:1985;875-882.
2. Beyer C., Banas C., Gomora P., Komisruk B.R. Prevention of the convulsant and hyperalgesic action of strychnine by intrathecal glycine and related amino acids. Pharmacol. Biochem. Behav. 29:1988;73-78.
3. Campbell N.J., Raja N.S., Meyer A.R., Mckinnon E.S. Myelinated afferents signal hyperalgesia associated with nerve injury. Pain. 32:1988;89-94.
4. Christophe, J., Kutzner, J.R., Nguyen-Bui, N.D., Damien, C., Chatelain, P. and Gillet, L., Conversion of orally administered 2-n-pentylaminoacetamide into glycinamide and glycine in the rat brain, Life Sci., 33 (1983) 533-541.
5. Curtis D.R., Hösli L., Johnston G.A.R. A pharmacological study of the depression of spinal neurons by glycine and related amino acids. Exp. Brain Res. 6:1968;1-18.
6. de Varebeke, P.J., Cavalier, R., David-Remacle, M. and Youdim, M.B.H., Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B, J. Neurochem., 50 (1988) 12011-1016.
7. de Varebeke P.J., Pauwels G., Buyse C., David-Remacle M., De Mey J., Roba J., Youdim M.B.H. The novel psychotropic agent milacemide is a specific enzyme activated inhibitor of brain monoamine oxidase. J. Neurochem. 53:1989;1109-1116.
8. Game C.J.A., Lodge D. The pharmacology of inhibition of the dorsal horn neurons by impulses in myelinated cutaneous afferents in the cat. Exp. Brain Res. 23:1975;75-84.
9. Houtkooper M.A., Van Oorschot C.A.E.H., Rentmeester T.W., Hoppener P.J.E.A., Onkelinx C. Double blind study of milacemide in hospitalised therapy resistant patients with epilepsy. Epilepsia. 27:1986;255-262.
10. Khandwala H., Hodge E., Loomis C.W. Comparable dose-dependent inhibition of AP-7 sensitive strychnine-allodynia and normal nociception by intravenous mexiletine in the rat. Pain. 72:1997;299-308.
11. Milne B., Duggan S., Jhamandas K., Loomis C.W. Innocuous hair deflection evokes a nociceptive-like activation of catechol oxidation in the rat locus coeruleus following intrathecal strychnine: a biochemical index of allodynia using in vivo voltammetry. Brain Res. 718:1996;198-202.
12. O'Brien E.M., Tipton K.F., McCrodden J.M., Youdim M.B.H. The interactions of milacemide with rat liver monoamine oxidase. Biochem. Pharmacol. 47:1994;617-623.
13. Onaka M., Minami T., Nishihara I., Ito S. Involvement of glutamate receptors in strychnine- and bicuculline-induced allodynia in conscious mice. Anesthesiology. 84:1996;1215-1222.
14. Pan Z.H., Slaughter M.M. Comparison of the action of glycine and related amino acids on the isolated third order neurons from the tiger salamander retina. Neuroscience. 64:1995;153-164.
15. Roba, J., Cavalier, R., Cordi, A., Gorissen, H., Herin, M., De Varebeke, P.J., Onkelinx, C., Remacle, M. and Van Dorsser, W., In: B.S. Meldrum and R.J. Porter (Ed.), Milacemide in New Antiepileptic Drugs, Libbey, London, 1986, pp. 179-190.
16. Rosse R.B., Schwatrz B.L., Leighton M.P., Davis R.E., Duetsch S.I. An NMDA intervention strategy in schizophrenia with low dose milacemide. Clin. Neuropharmacol. 14:1991;268-272.
17. Sawler, S., Khandwala, H., Harley, C. and Loomis, C.W., Hair deflection evokes localized nociceptive-like activation of glycogen phoshorylase activity in the cortex of intrathecal strychnine-treated rats, Society for Neuroscience, New Orleans, 1997.
18. Semba J., Patsalos P.N. Milacemide effects on the temporal inter-relationship of amino acids and monoamine metabolites in rat cerebrospinal fluid. Eur. J. Pharmacol. 230:1993;321-326.
19. Semba J., Curzon G., Patsalos P.N. Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: milacemide. Br. J. Pharmacol. 108(4):1993;1117-1124.
20. Sherman S.E., Loomis C.W. Morphine insensitive allodynia is produced by intrathecal strychnine in the lightly anesthetized rat. Pain. 56:1994;17-29.
21. Sherman S.E., Loomis C.W. Strychnine-dependent allodynia in the urethane-anesthetized rat is segmentally distributed and prevented by intrathecal glycine and betaine. Can. J. Physiol. Pharmacol. 73:1995;1698-1705.
22. Sherman S.E., Loomis C.W. Strychnine-sensitive modulation is selective for non-noxious somatosensory input in the spinal cord. Pain. 66:1996;321-330.
23. Sherman S.E., Luo L., Dostrovsky D.O. Spinal strychnine alters response properties of nociceptive-specific neurons in rat medial thalamus. J. Neurophysiol. 78:1997;628-637.
24. Tallarida, R.J. and Murray, R.B., Manual of Pharmacological Calculations, Springer-Verlag, New York, 1987, pp. 10-30.
25. Todd A.J. An electron microscope study of glycine-like immunoreactivity in lamina I-III of the spinal dorsal horn of the rat. Neuroscience. 39:1990;387-394.
26. Todd A.J., Sullivan A.C. Light microscopic study of the coexistence of GABA-like and glycine-like immunoreactivities in the spinal cord of the rat. J. Comp. Neurol. 296:1990;496-505.
27. Van Dorsser W., Barris D., Cordi A., Roba J. Anticonvulsant activity of milacemide. Arch. Int. Pharmacodyn. 266:1983;234.
28. Yaksh T.L. Behavioral and autonomic correlates of tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain. 37:1989;111-123.
29. Youdim M.B.H., Kerem D., Duvdevani Y. The glycine pro-drug, milacemide, increases the seizure threshold due to hyperbaric oxygen: prevention by L-deprenyl. Eur. J. Pharmacol. 150:1988;381-384.